about
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypesPyogenic bacterial infections in humans with MyD88 deficiencyIL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation databaseThe NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory responseB cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleenThe inflammasome pathway in stable COPD and acute exacerbationsDescription of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation.Inherited biallelic CSF3R mutations in severe congenital neutropenia.An international registry on autoinflammatory diseases: the Eurofever experience.Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agentsLTBP2 and CYP1B1 mutations and associated ocular phenotypes in the Roma/Gypsy founder population.Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis.Somatic NOD2 mosaicism in Blau syndromeFamilial CD8 deficiency due to a mutation in the CD8 alpha gene.High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study.Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variantsNatural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain.Brief Report: whole-exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndrome.Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells.Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis.Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center.Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children.Newly Described Autoinflammatory Diseases in Pediatric Dermatology.Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes.Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion.A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever.Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes.Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism.Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype.[A 37-years old man with recurrent episodes of fever and abdominal pain].Clinical and genetic features of hereditary periodic fever syndromes in Hispanic patients: the Chilean experience.
P50
Q24329184-CA5077FF-5EC0-482B-9CC5-FAEF0A6FE958Q24653859-F628CCAC-4D45-4032-ABFA-B9DDD842E697Q27022796-AF97E249-C2DB-4FAE-AF7C-0D4FE844315AQ28242527-A8D1FBE3-4FDE-4E5C-9877-1C8295C12D43Q28256100-1D7915C4-A120-4D07-A0A8-EF7CB56D1AFFQ28598391-76361237-8530-4839-90BD-4A7B5FB9AEDEQ30750457-064FC748-606A-42FF-85DC-3C52B5D4A954Q33749664-8E8A5F9B-6EF2-49CE-9730-42C390E22DE5Q34257724-B989755A-A738-485B-8E9C-B9876A29FCAFQ34451635-538009F7-E65B-4B64-8D8E-BFFBA3356371Q34705288-4BBD89D1-CFF4-492E-84E9-73CC48D12E2CQ35012945-AA01DEBD-6FCA-4899-B82E-937231FF66F1Q35443835-219000DB-A947-482E-A4EC-C1749954251DQ35677969-B564BAEC-B830-40E7-9F6C-16C14A501845Q35931519-742F8741-6048-4F95-ABDF-DE278F3651E5Q36167336-94059B5F-4E07-4595-956C-E49BA92EA5DDQ36399888-0247043B-0AE6-404C-BE70-62C5202DE8A3Q36670874-EA6D85FB-A4C3-40B5-82BD-75C9A230367FQ36967163-31C6FC1C-AF5C-4CAE-9A1D-78B4669F25B5Q37401815-85F52C84-9D57-45F7-9EFB-88E6497D171EQ37715652-673BFB82-1794-4F24-87AC-78882AF9C9E2Q37734578-11C72215-902F-4572-9572-31A12A5CC325Q38153093-09F32EEF-F308-467F-8B41-A25B40A3A0A1Q38311291-41242EE1-4B21-4C07-A3DB-D46114D16F80Q38572205-A9B6DB6D-3416-43DA-B3E0-AB2187EBAC79Q38736272-65DD732A-E9B9-4AD2-A200-CB0D543D009AQ38971704-89279519-F156-4C50-8D72-2F154D34A842Q39025157-F95BD0E1-D8F2-47F3-B1C7-34EB4BF0B56AQ39042964-F3555D5D-7EE3-4C47-B6F7-8DAC0D455DB9Q39373924-E3B455DB-FE43-4C2D-8F8A-83E4E2E1F2B8Q39411661-DA1FCDD7-5148-40D4-90C2-640667B88822Q40042168-4DE1F68C-E39F-4E22-8A02-443B70341707Q40044596-1C9F54C6-CE78-4D5F-88AD-88AB9591B2A3Q40057989-493507BD-093F-4C54-8C8E-64C0F3D62872Q40097682-86A010EA-A4CA-4392-BB0E-B82014D9CCC4Q40102364-995502E3-6452-43F3-B56E-86FFB87F1518Q40129439-A1F1E2D0-8FA0-4E4C-9889-D2FFC6136498Q40213358-E2CB7201-DA9F-432C-9265-5B2F27D2FAFFQ40284339-D9E65206-C435-4EC8-83D7-8D6D83C59AF5Q40298213-5577D679-10EF-44C9-9C08-C770B63023DE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan I Arostegui
@ast
Juan I Arostegui
@de
Juan I Arostegui
@en
Juan I Arostegui
@es
Juan I Arostegui
@fr
Juan I Arostegui
@nl
Juan I Arostegui
@sl
type
label
Juan I Arostegui
@ast
Juan I Arostegui
@de
Juan I Arostegui
@en
Juan I Arostegui
@es
Juan I Arostegui
@fr
Juan I Arostegui
@nl
Juan I Arostegui
@sl
altLabel
Juan I. Arostegui
@en
prefLabel
Juan I Arostegui
@ast
Juan I Arostegui
@de
Juan I Arostegui
@en
Juan I Arostegui
@es
Juan I Arostegui
@fr
Juan I Arostegui
@nl
Juan I Arostegui
@sl
P106
P21
P31
P496
0000-0003-4757-504X